You know, there could be a very silver lining to a well timed reverse split. If the reverse split were implemented in September, it could actually cause an interesting effect. While the ticker has the "D" on it, no one will be able to sell it, short it, dilute it, etc., but people will still be able to buy MYDXD. So, if that happens to coincide with the impending rescheduling action that the DEA has to take by September 23rd at the latest(90 days from FDA approval of CBD drug on June 25th), then a lot of buying volume could pour in while no one can sell. I know that Slimpen is not the same pen as the ecosmartpen but the formulation is being done by MYDX, and I noticed that after Slimpen changed their launch date from July 18th to "summer 2018", they ultimately changed it to September 22, 2018, possibly to line up closer to that DEA deadline.

Just some food for thought...